MOLMED LOGO Impact Factor 3.411*
rss
HOME
 
Top Ten

  1. López-Lázaro M. A New View of Carcinogenesis and an Alternative Approach to Cancer Therapy. Mol Med. 16: 144-53.

  2. Jackson PL, et al. Human Neutrophil Elastase-Mediated Cleavage Sites of MMP-9 and TIMP-1: Implications to Cystic Fibrosis Proteolytic Dysfunction. Mol Med. 2010 Jan 29. [Epub ahead of print]

  3. Jacob A, et al. Ghrelin as a Novel Therapy for Radiation Combined Injury. Mol Med. 16: 137-43.

  4. Piperi C, et al. High Incidence of MGMT and RARβ Promoter Methylation in Primary Glioblastomas: Association with Histopathological Characteristics, Inflammatory Mediators and Clinical Outcome. Mol Med. 16: 1-9.

  5. Brik R, et al. Salivary Antioxidants and Metalloproteinases in Juvenile Idiopathic Arthritis. Mol Med. 16: 122-28.

  6. Ziello, et al. Cellular Endocytosis and Gene Delivery. Mol Med. 2010 Feb 3. [Epub ahead of print www.molmed.org]

  7. Lipnick, et al. The Interferon Gamma-Induced Human Guanylate Binding Protein-1 Inhibits Mammary Tumor Growth in Mice. Mol Med. 2010 Feb 5. [Epub ahead of print www.molmed.org]

  8. Fraga-Silva RA, et al. ACE2 Activation Promotes Anti-Thrombotic Activity. Mol Med. 2010 Jan 29. [Epub ahead of print]

  9. Pastar I, et al. Attenuation of TGFbeta Signaling Pathway in Chronic Venous Ulcers. Mol Med. 16: 92-101.

  10. Fornes R, et al. Changes in the Expression of Insulin Signaling Pathway Molecules in Endometria from Polycystic Ovary Syndrome Women with or without Hyperinsulinemia. Mol Med. 16: 129-36.

     

FEINSTEIN LOGO * ©Thomson ISI Journal Citation Reports 2008